Tales of Woe: How Dysfunctional Regulation Has Decimated Entire Sectors of Biotechnology
“To observe government is to observe the absence of accountability,” James Freeman wrote in the Wall Street Journal.1 That’s certainly true of unwise regulation of many innovative technologies; and modern biotechnology, also known as “genetic engineering (GE)” or “genetic modification (GM),” perhaps along with civilian applications of nuclear power, could be the poster child.
Over four decades, genetic engineering has produced monumental scientific, technological, economic, and humanitarian advances in medicine and agriculture. And yet, because of persistent over-regulation and the relentless antagonism of self-interested activists, it has realized only a fraction of its potential. Indeed, entire sectors of genetic engineering, some or all of which had the potential to produce the Next Big Thing in American innovation, have been decimated. . .